OKI-355
/ OnKure
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 02, 2026
OnKure plans to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for each of OKI‑345 and OKI‑355 in the first half of 2027
(GlobeNewswire)
IND • Solid Tumor
1 to 1
Of
1
Go to page
1